ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 93 filers reported holding ADURO BIOTECH INC in Q3 2016. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $14,000 | -51.7% | 11,639 | -58.0% | 0.00% | – |
| Q3 2019 | $29,000 | -21.6% | 27,692 | +14.8% | 0.00% | – |
| Q2 2019 | $37,000 | -60.6% | 24,124 | +1.7% | 0.00% | – |
| Q1 2019 | $94,000 | +80.8% | 23,715 | +20.1% | 0.00% | – |
| Q4 2018 | $52,000 | -85.2% | 19,742 | -58.8% | 0.00% | – |
| Q3 2018 | $352,000 | +62.2% | 47,915 | +54.5% | 0.00% | – |
| Q2 2018 | $217,000 | -0.5% | 31,019 | +32.4% | 0.00% | – |
| Q1 2018 | $218,000 | +38.9% | 23,428 | +11.7% | 0.00% | – |
| Q4 2017 | $157,000 | -61.6% | 20,980 | -45.5% | 0.00% | – |
| Q3 2017 | $409,000 | +142.0% | 38,490 | +159.5% | 0.00% | – |
| Q2 2017 | $169,000 | -28.7% | 14,831 | -32.8% | 0.00% | – |
| Q1 2017 | $237,000 | -25.5% | 22,086 | -20.9% | 0.00% | – |
| Q4 2016 | $318,000 | -23.4% | 27,931 | -16.4% | 0.00% | – |
| Q3 2016 | $415,000 | +2.2% | 33,413 | -7.0% | 0.00% | – |
| Q2 2016 | $406,000 | -39.9% | 35,947 | -31.8% | 0.00% | -100.0% |
| Q1 2016 | $676,000 | -5.1% | 52,685 | +108.1% | 0.00% | 0.0% |
| Q4 2015 | $712,000 | – | 25,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 640,595 | $4,708,000 | 1.20% |
| BVF INC/IL | 287,776 | $2,115,000 | 0.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 111,542 | $820,000 | 0.18% |
| Sofinnova Investments, Inc. | 189,579 | $1,393,000 | 0.12% |
| CENTAURUS FINANCIAL, INC. | 85 | $624,000 | 0.11% |
| Artal Group S.A. | 550,000 | $4,043,000 | 0.10% |
| Vident Investment Advisory, LLC | 305,311 | $2,244,000 | 0.09% |
| Virtus ETF Advisers LLC | 61,463 | $452,000 | 0.05% |
| Foundry Partners, LLC | 106,907 | $786,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 239,301 | $1,759,000 | 0.02% |